Leukine (sargramostim) / Partner Therap 
Welcome,         Profile    Billing    Logout  
 449 Diseases   58 Trials   58 Trials   3605 News 


«12...1314151617181920212223...2425»
  • ||||||||||  Leukine (sargramostim) / Partner Therap, ViraferonPeg (peginterferon-?-2b) / Merck (MSD)
    Trial completion, Phase classification, Trial primary completion date, Combination therapy:  High-Dose Gleevec Alone or in Combination With Peg-Intron and GM-CSF in Early Phase Chronic Myelogenous Leukemia (CML) (clinicaltrials.gov) -  Aug 20, 2015   
    P3,  N=94, Completed, 
    Trial primary completion date: Jan 2013 --> Oct 2012 Active, not recruiting --> Completed | Phase classification: PN/A --> P3 | Trial primary completion date: Nov 2016 --> Aug 2015
  • ||||||||||  Leukine (sargramostim) / Partner Therap, IMA-901 / Immatics, sunitinib / Generic mfg.
    Trial completion, IO biomarker, Metastases:  IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma (clinicaltrials.gov) -  Aug 19, 2015   
    P3,  N=330, Completed, 
    Active, not recruiting --> Completed | Phase classification: PN/A --> P3 | Trial primary completion date: Nov 2016 --> Aug 2015 Active, not recruiting --> Completed
  • ||||||||||  Leukine (sargramostim) / Partner Therap
    Trial completion, Enrollment change:  Sargramostim for Myeloid Dendritic Cell Deficiency (clinicaltrials.gov) -  May 21, 2015   
    P1,  N=2, Completed, 
    Initiation date: Feb 2015 --> Jun 2015 Recruiting --> Completed | N=15 --> 2
  • ||||||||||  Leukine (sargramostim) / Partner Therap
    Trial completion date, Trial termination:  GM-CSF in Patients With Pulmonary Alveolar Proteinosis (clinicaltrials.gov) -  Apr 19, 2015   
    P2,  N=48, Terminated, 
    Active, not recruiting --> Completed Trial completion date: Sep 2004 --> Dec 2005 | Recruiting --> Terminated
  • ||||||||||  NeuVax (nelipepimut-S) / Dr. Reddy's
    Enrollment closed, Trial primary completion date:  PRESENT: Efficacy and Safety Study of NeuVax (clinicaltrials.gov) -  Apr 15, 2015   
    P3,  N=700, Active, not recruiting, 
    Trial completion date: Sep 2004 --> Dec 2005 | Recruiting --> Terminated Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2017 --> Apr 2018
  • ||||||||||  Leukine (sargramostim) / Partner Therap, Herceptin (trastuzumab) / Roche
    Phase classification:  Biological Therapy in Treating Women With Stage IV Breast Cancer (clinicaltrials.gov) -  Mar 31, 2015   
    P1,  N=6, Completed, 
    Trial primary completion date: Nov 2015 --> Nov 2016 Phase classification: P1/2 --> P1